Related references
Note: Only part of the references are listed.Specific binding of [H-3]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death
Javier Ballesteros et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Platelet imidazoline receptors as state marker of depressive symptomatology
John Piletz et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
CRH1 receptor antagonists for the treatment of depression and anxiety
Marcus Ising et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2007)
Sympathoexcitation of moxonidine in the caudal ventrolateral medulla is dependent on I1-imidazoline receptors in anesthetized rats
Li-Gang Wang et al.
NEUROSCIENCE LETTERS (2007)
The effect of 1-(4,5-dihydro-1H-imidazol-2-yl) isoquinoline on monoamine release and turnover in the rat frontal cortex
Haya Abu Ghazaleh et al.
NEUROSCIENCE LETTERS (2007)
The diurnal cortisol cycle in delinquent male adolescents and normal controls
Arne Popma et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Physiology and neurobiology of stress and adaptation: Central role of the brain
Bruce S. McEwen
PHYSIOLOGICAL REVIEWS (2007)
Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test
Mariana P. Zeidan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder
C. S. de Kloet et al.
PSYCHONEUROENDOCRINOLOGY (2007)
Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells
Zheng Sun et al.
JOURNAL OF NEUROCHEMISTRY (2007)
In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO:: Evidence for two distinct I2 binding sites
Louise M. Paterson et al.
NEUROPHARMACOLOGY (2007)
Candidate gene polymorphisms in the serotonergic pathway: Influence on depression symptomatology in an elderly population
Lene Christiansen et al.
BIOLOGICAL PSYCHIATRY (2007)
Distribution and cellular localization of imidazoleacetic acid-ribotide, an endogenous ligand at imidazol(in)e and adrenergic receptors, in rat brain
Victor L. Friedrich et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2007)
Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems
Samia Regiane Lourenco Joca et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2007)
Anxiolytic effect of agmatine in rats and mice
Zheng-Hua Gong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats
Hagit Cohen et al.
BIOLOGICAL PSYCHIATRY (2006)
Nischarin as a functional imidazoline (I1) receptor
Jian Zhang et al.
FEBS LETTERS (2006)
Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD
R Yehuda et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear
YL Yang et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Glucocorticoids reduce phobic fear in humans
LM Soravia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Reduced hemodynamic responses to physical and mental stress under low-dose rilmenidine in healthy subjects
Renata Rodrigues Teixeira de Castro et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice
NJ Anderson et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Harmane inhibits serotonergic dorsal raphe neurons in the rat
K Touiki et al.
PSYCHOPHARMACOLOGY (2005)
Regulation of p21-activated kinase-independent Rac1 signal transduction by nischarin
PJ Reddig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Association study of a Monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response
YWY Yu et al.
NEUROPSYCHOPHARMACOLOGY (2005)
The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders
DE Grigoriadis
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder
JW Smoller et al.
BIOLOGICAL PSYCHIATRY (2005)
Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain
N MacInnes et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Association analysis of monoamine genes with measures of depression and anxiety in a selected community sample of siblings
MW Nash et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
A case of seasonal bipolar disorder exacerbated by Cushing's disease
AM Ghadirian et al.
COMPREHENSIVE PSYCHIATRY (2005)
Human monoamine oxidase is inhibited by tobacco smoke:: β-carboline alkaloids act as potent and reversible inhibitors
T Herraiz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Developmental psychopathology and neurobiology of aggression
JK Gollan et al.
DEVELOPMENT AND PSYCHOPATHOLOGY (2005)
Mitogen-activated protein kinase phosphorylation in the rostral ventrolateral medulla plays a key role in imidazoline (I-1)-receptor-mediated hypotension
J Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery:: A randomized study
G Schelling et al.
BIOLOGICAL PSYCHIATRY (2004)
Sympathetic responses to stress and rilmenidine in 2K1C rabbits - Evidence of enhanced nonvascular effector mechanism
GA Head et al.
HYPERTENSION (2004)
Imidazoline2 (I2) receptor- and α2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats
DP Finn et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Dysregulation in the suicide brain:: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptorsubunits in frontal cortical brain region
Z Merali et al.
JOURNAL OF NEUROSCIENCE (2004)
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands
A Holt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Imidazoleacetic acid-ribotide: An endogenous ligand that stimulates imidazol(in)e receptors
GD Prell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Imidazoline binding sites and their ligands: An overview of the different chemical structures
C Dardonville et al.
MEDICINAL RESEARCH REVIEWS (2004)
Harmane and harmalan are bioactive components of classical clonidine-displacing substance
CA Parker et al.
BIOCHEMISTRY (2004)
Glucose dependence of imidazoline-induced insulin secretion -: Different characteristics of two ATP-sensitive K+ channel-blocking compounds
C Bleck et al.
DIABETES (2004)
Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers
CM Pariante et al.
PSYCHOPHARMACOLOGY (2004)
Moderate differences in circulating corticosterone alter receptor-mediated regulation of 5-hydroxytryptamine neuronal activity
SJ Judge et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
The putative imidazoline receptor agonist, harmane, promotes intracellular calcium mobilisation in pancreatic β-cells
PE Squires et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress
RR Wenzel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Corticotropin-releasing factor in posttraurnatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects
FJ Sautter et al.
BIOLOGICAL PSYCHIATRY (2003)
Effects of the β-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans
EJ Cooper et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Nischarin inhibits Rac induced migration and invasion of epithelial cells by affecting signaling cascades involving PAK
SK Alahari
EXPERIMENTAL CELL RESEARCH (2003)
Elevated concentrations of CRF in the locus coeruleus of depressed subjects
G Bissette et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Antidepressant-like effect of agmatine and its possible mechanism
YF Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test
DP Finn et al.
PSYCHOPHARMACOLOGY (2003)
Agmatine induces anxiolysis in the elevated plus maze task in adult rats
D Lavinsky et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Neuroendocrine aspects of hypercortisolism in major depression
KJ Parker et al.
HORMONES AND BEHAVIOR (2003)
Distribution of [3H]BU224, a selective imidazoline I2 binding site ligand, in rat brain
ESJ Robinson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Imidazoline2 (I2) binding site- and α2-adrenoceptor-mediated modulation of central noradrenergic and HPA axis function in control rats and chronically stressed rats with adjuvant-induced arthritis
DP Finn et al.
NEUROPHARMACOLOGY (2002)
Insulin receptor substrate 4 associates with the protein IRAS
H Sano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Agmatine produces antidepressant-like effects in two models of depression in mice
ADE Zomkowski et al.
NEUROREPORT (2002)
Imidazoline antihypertensive drugs: a critical review on their mechanism of action
B Szabo
PHARMACOLOGY & THERAPEUTICS (2002)
Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment
A Halaris et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK)
L Edwards et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Imidazoline binding sites in the endocrine pancreas: Can they fulfil their potential as targets for the development of new insulin secretagogues?
NG Morgan et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Stimulatory effect of harmane and other β-carbolines on locus coeruleus neurons in anaesthetized rats
E Ruiz-Durántez et al.
NEUROSCIENCE LETTERS (2001)
Glucose-induced insulin secretion is potentiated by a new imidazoline compound
HJ Mest et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2001)
The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo
A Sastre-Coll et al.
NEUROSCIENCE LETTERS (2001)
Imidazoline I1 receptor-induced activation of phosphatidylcholine-specific phospholipase C elicits mitogen-activated protein kinase phosphorylation in PC12 cells
J Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2001)
Selective imidazoline I-2 ligands do not show antidepressant-like activity in the forced swim test in mice
MF O'Neill et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2001)
Imidazoline receptors: Possible involvement in the pathophysiology and treatment of depression
A Halaris et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
Nischarin, a novel protein that interacts with the integrin α5 subunit and inhibits cell migration
SK Alahari et al.
JOURNAL OF CELL BIOLOGY (2000)
The effect of the alpha-2-adrenergic agonist, clonidine, on secretion patterns and rates of adrenocorticotropic hormone and its secretagogues in the horse
SL Alexander et al.
JOURNAL OF NEUROENDOCRINOLOGY (2000)
Effect of clonidine on plasma ACTH, cortisol and melatonin in children
A Muñóz-Hoyos et al.
JOURNAL OF PINEAL RESEARCH (2000)
Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
RA Glennon et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Imidazoline receptor antisera-selected (IRAS) cDNA: Cloning and characterization
JE Piletz et al.
DNA AND CELL BIOLOGY (2000)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Activation of I2-imidazoline receptors enhances supraspinal morphine analgesia in mice:: a model to detect agonist and antagonist activities at these receptors
P Sánchez-Blázquez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Is agmatine a novel neurotransmitter in brain?
DJ Reis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
The specificity of stress responses to different nocuous stimuli: Neurosteroids and depression
B Dubrovsky
BRAIN RESEARCH BULLETIN (2000)
Isolation of RP-HPLC pure clonidine-displacing substance from NG108-15 cells
CA Parker et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Harmane produces hypotension following microinjection into the RVLM: possible role of I-1-imidazoline receptors
IF Musgrave et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
